Atópiás dermatitisz (ekcéma): vizsgálatok itt: Dánia
8 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Where
- Copenhagen Nv, Odense C
- Életkor
- 6 hónap to 11 év
- People
- 195 worldwide
- Run by
- LEO Pharma
See details and how to joinNCT06311682 · EU 2023-503630-44-00 - No phaseTaking peopleRole of Interleukin-13 Pathways on Pain and Itch Sensitivity
- Where
- Aalborg, Gistrup
- Életkor
- 18 év to 60 év
- People
- 20
- Run by
- Aalborg University
See details and how to joinNCT06503510 - 3. fázisNot yet taking people in DániaA Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic Dermatitis
- Where
- Aarhus N, Copenhagen Nv, Odense C
- Életkor
- 12 év and over
- People
- 230 worldwide
- Run by
- Almirall, S.A.
See details and how to joinNCT07873801 · EU 2025-525133-31-00 - No phaseTaking peopleChanges in Skin Myco- and Microbiome After Lebrikizumab Treatment
- Where
- Copenhagen
- Életkor
- 18 év and over
- People
- 60
- Run by
- University Hospital Bispebjerg and Frederiksberg
See details and how to joinNCT07807228 - 1. fázisTaking peopleA 3-part Study of SYX-5219 in Healthy Volunteers and Participants With Atopic Dermatitis
- Where
- Herlev
- Életkor
- 18 év to 65 év
- People
- 149 worldwide
- Run by
- Sitryx Therapeutics Ltd
See details and how to joinNCT07558668 - 3. fázisTaking peopleFish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma
- Where
- Gentofte Municipality
- Életkor
- 18 év to 45 év
- People
- 2000
- Run by
- Professor Klaus Bønnelykke
See details and how to joinNCT06560255 - 3. fázisTaking peopleVItamin D in pregnanCy for prevenTion Of eaRlY Childhood Asthma
- Where
- Gentofte Municipality
- Életkor
- 18 év to 45 év
- People
- 2000
- Run by
- Professor Klaus Bønnelykke
See details and how to joinNCT06570889 - No phaseTaking peopleA Study to Assess the Impact of Lebrikizumab on Health-Related Well-Being and Control of Skin Manifestations in Participants With Moderate-to-Severe Atopic Dermatitis
- Where
- Aarhus
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Almirall, S.A.
See details and how to joinNCT06815380